Preetam Shah's Insider Trades & SAST Disclosures
Preetam Shah's most recent trade in Elicio Therapeutics Inc. was a trade of 191,624 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Preetam Shah.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Elicio Therapeutics Inc. | Preetam Shah | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2025 | 191,624 | 191,624 | - | - | Stock Option (Right to Buy) | |
| Cidara Therapeutics Inc | Preetam Shah | Chief Financial Officer | 30 Sep 2024 | 130,087 | 130,087 | - | - | Employee Stock Option (right to buy) | ||
| Cidara Therapeutics Inc | Preetam Shah | CFO & CBO | 15 Mar 2024 | 217,500 | 217,500 | - | - | Employee Stock Option (right to buy) | ||
| Cidara Therapeutics Inc | Preetam Shah | CFO & CBO | 15 Mar 2024 | 108,750 | 335,960 (0%) | 0% | 0 | Common Stock | ||
| Cidara Therapeutics Inc | Preetam Shah | CFO & CBO | 11 Mar 2024 | 18,931 | 227,210 (0%) | 0% | 0.7 | 12,680 | Common Stock | |
| Cidara Therapeutics Inc | Preetam Shah | CFO & CBO | 27 Mar 2023 | 180,000 | 180,000 | - | - | Employee Stock Option (right to buy) | ||
| Cidara Therapeutics Inc | Preetam Shah | CFO & CBO | 27 Mar 2023 | 90,000 | 238,141 (0%) | 0% | 0 | Common Stock | ||
| Cidara Therapeutics Inc | Preetam Shah | CFO & CBO | 13 Mar 2023 | 6,648 | 148,141 (0%) | 0% | 1.5 | 10,171 | Common Stock | |
| Cidara Therapeutics Inc | Preetam Shah | CFO & CBO | 15 Sep 2022 | 50,000 | 0 | - | - | Restricted Stock Unit | ||
| Cidara Therapeutics Inc | Preetam Shah | CFO & CBO | 15 Sep 2022 | 50,000 | 166,431 (0%) | 0% | 0 | Common Stock | ||
| Cidara Therapeutics Inc | Preetam Shah | CFO & CBO | 15 Sep 2022 | 15,642 | 150,789 (0%) | 0% | 0.8 | 12,035 | Common Stock | |
| Cidara Therapeutics Inc | Preetam Shah | CFO & CBO | 31 Mar 2022 | 102,500 | 102,500 | - | - | Employee Stock Option (right to buy) | ||
| Cidara Therapeutics Inc | Preetam Shah | CFO & CBO | 31 Mar 2022 | 66,001 | 137,251 (0%) | 0% | 0 | Common Stock | ||
| Cidara Therapeutics Inc | Preetam Shah | CFO & CBO | 31 Mar 2022 | 51,250 | 71,250 (0%) | 0% | 0 | Common Stock | ||
| Cidara Therapeutics Inc | Preetam Shah | CFO & CBO | 31 Mar 2022 | 24,820 | 112,431 (0%) | 0% | 0.8 | 20,601 | Common Stock | |
| Cidara Therapeutics Inc | Preetam Shah | CFO & CBO | 12 Nov 2021 | 20,000 | 20,000 (0%) | 0% | 1.5 | 30,800 | Common Stock | |
| Cidara Therapeutics Inc | Preetam Shah | CFO & CBO | 01 Sep 2021 | 311,850 | 311,850 | - | - | Stock Option (right to buy) | ||
| Cidara Therapeutics Inc | Preetam Shah | CFO & CBO | 01 Sep 2021 | 50,000 | 50,000 | - | - | Restricted Stock Unit | ||
| Brainstorm Cell Therapeuti... | Preetam Shah | EVP, CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.64 per share. | 30 Dec 2020 | 25,000 | 11,600 (0%) | 0% | 4.6 | 116,000 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges